Adaptive Biotechnologies to report Q2 2026 earnings on July 29 with webcast call.

Adaptive Biotechnologies announced it will release its financial results for the second quarter of 2026 after market close on July 29, 2026. The company will host a webcast conference call at 1:30 p.m. Pacific Time to discuss the results. Adaptive Biotechnologies focuses on using the adaptive immune system's genetics to develop diagnostic and therapeutic products for diseases like cancer and autoimmune disorders. Investors can access the live webcast on the company’s website, with a replay available within 24 hours.